These suggest that correcting DRP1 activity might confer tolerance to cytotoxicity from p-Tau and Aβ (Manczak and Reddy, 2012a; Kuruva et al., 2017; Reddy and Oliver, 2019) and there is a need for further investigation into the identified regulation underlying AD events. Here, DNM1L is linked to Alzheimer disease.